Clinical Trial Confirms Efficacy of Senolytic Agent PCC and Cellumiva(TM)
Express Rx, recently announced the completion of a clinical study started in 2022, on its novel anti-aging complex, Cellumiva™, being the one of the first to apply the potent senolytic flavonoid,Procyanidin C1(PCC) to human trial. The study, conducted over 12 weeks with a cohort of 72 participants aged 45-65, employed SA-β-gal staining to quantify senescent cell clearance and a skin-specific methylome model to analyze the biological age of skin....
Read more








